Pyxis Oncology (PYXS) News Today $1.10 -0.02 (-1.79%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.12 +0.01 (+1.36%) As of 08/1/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYXS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Purchased by Pier 88 Investment Partners LLCJuly 22, 2025 | marketbeat.comPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of "Moderate Buy" from AnalystsJuly 11, 2025 | marketbeat.comPyxis Oncology Inc News (PYXS) - Investing.comJuly 8, 2025 | investing.comPyxis Oncology (NASDAQ:PYXS) Stock Price Up 3.6% - Time to Buy?July 8, 2025 | marketbeat.comPyxis Oncology Chief Financial, Operating Officer Pamela Connealy Retires >PYXSJuly 3, 2025 | marketwatch.comPyxis Oncology Appoints New Principal Financial OfficerJuly 3, 2025 | tipranks.comPyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 30, 2025 | globenewswire.comPyxis Oncology Insiders Lose Out As Stock Sinks To US$1.14June 19, 2025 | finance.yahoo.comPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of "Moderate Buy" from BrokeragesJune 16, 2025 | marketbeat.comPyxis Oncology, Inc. (NASDAQ:PYXS) Shares Sold by Deutsche Bank AGJune 5, 2025 | marketbeat.comPyxis Oncology Reports Increased Losses Amidst Ongoing R&D InvestmentsMay 30, 2025 | tipranks.comMillennium Management LLC Has $4.65 Million Stock Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS)May 30, 2025 | marketbeat.comPyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of "Moderate Buy" by AnalystsMay 24, 2025 | marketbeat.comPyxis Oncology Q2 EPS Forecast Decreased by HC WainwrightMay 23, 2025 | marketbeat.comHC Wainwright Weighs in on Pyxis Oncology Q1 EarningsMay 22, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Globus Medical (GMED) and Ramsay Health Care (OtherRMSYF)May 22, 2025 | theglobeandmail.comPyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from HC WainwrightMay 21, 2025 | marketbeat.comLeerink Partnrs Forecasts Pyxis Oncology FY2029 EarningsMay 21, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Raises Position in Pyxis Oncology, Inc. (NASDAQ:PYXS)May 19, 2025 | marketbeat.comRidgeback Capital Investments L.P. Takes $560,000 Position in Pyxis Oncology, Inc. (NASDAQ:PYXS)May 17, 2025 | marketbeat.comPyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | globenewswire.comPyxis Oncology to Participate in Two Upcoming Investor ConferencesMay 14, 2025 | globenewswire.comPyxis Oncology (PYXS) to Release Earnings on TuesdayMay 8, 2025 | marketbeat.comNew Approaches to Tumor Targeting Are Driving the Next Wave of Oncology BreakthroughsMay 8, 2025 | baystreet.caBoothbay Fund Management LLC Sells 201,674 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS)May 5, 2025 | marketbeat.comPyxis Oncology reveals promising preclinical data for cancer drugApril 27, 2025 | investing.comPyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADCApril 25, 2025 | globenewswire.comPyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology ForumApril 2, 2025 | globenewswire.comPyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025March 25, 2025 | globenewswire.comStifel Nicolaus Keeps Their Buy Rating on Pyxis Oncology (PYXS)March 24, 2025 | markets.businessinsider.comPyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Rating of "Moderate Buy" by BrokeragesMarch 23, 2025 | marketbeat.comHC Wainwright Forecasts Stronger Earnings for Pyxis OncologyMarch 22, 2025 | marketbeat.comWilliam Blair Comments on Pyxis Oncology Q1 EarningsMarch 22, 2025 | marketbeat.comWilliam Blair Comments on Pyxis Oncology FY2027 EarningsMarch 21, 2025 | marketbeat.comPyxis Oncology (NASDAQ:PYXS) Given Outperform Rating at Royal Bank of CanadaMarch 20, 2025 | marketbeat.comRBC Capital Remains a Buy on Pyxis Oncology (PYXS)March 20, 2025 | markets.businessinsider.comPyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC WainwrightMarch 20, 2025 | marketbeat.comPyxis Oncology (NASDAQ:PYXS) Releases Earnings Results, Hits ExpectationsMarch 19, 2025 | marketbeat.comPyxis Oncology reports FY24 EPS ($1.32), consensus ($1.09)March 18, 2025 | markets.businessinsider.comPyxis Oncology (PYXS) Gets a Hold from William BlairMarch 18, 2025 | markets.businessinsider.comPyxis Oncology Advances Cancer Therapeutics with MICVOMarch 18, 2025 | tipranks.comPyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 18, 2025 | globenewswire.comPyxis Oncology (PYXS) to Release Earnings on ThursdayMarch 13, 2025 | marketbeat.comPyxis Oncology to Participate at the Leerink Partners Global Healthcare ConferenceMarch 3, 2025 | globenewswire.comPyxis Oncology granted Fast Track designation for PYX-201 monotherapyFebruary 26, 2025 | markets.businessinsider.comPyxis Oncology rises on FDA fast track tag for lead assetFebruary 26, 2025 | msn.comPyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck CancerFebruary 26, 2025 | globenewswire.comPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Recommendation of "Moderate Buy" from BrokeragesFebruary 26, 2025 | marketbeat.comPyxis Oncology (NASDAQ:PYXS) Shares Down 4.7% - Here's What HappenedFebruary 25, 2025 | marketbeat.comPyxis Oncology initiates new PYX-201 trial, initiates cohort expansionsFebruary 4, 2025 | markets.businessinsider.com Get Pyxis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for PYXS and its competitors with MarketBeat's FREE daily newsletter. Email Address PYXS Media Mentions By Week PYXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PYXS News Sentiment▼0.000.53▲Average Medical News Sentiment PYXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PYXS Articles This Week▼02▲PYXS Articles Average Week Get Pyxis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for PYXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALDX News IVA News VOR News ESPR News SCPH News BNTC News HRTX News MREO News TKNO News ANNX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PYXS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYXS Stock Alerts